Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute of Ophthalmology

Home
Menu

Adult vitelliform Macular Degeneration

Adult vitelliform Macular Degeneration (AVMD) is an adult onset form of Bests disease.

What is Adult vitelliform Macular Degeneration (AVMD)?Ìý

AVMD is aÌýdominantly inheritedÌýbestrophinopathyÌýwhich affects theÌýRetinal Pigment Epithelium (RPE).ÌýIt is very similar toÌýBest disease (learn more Best disease here),Ìýso much so that manyÌýargueÌýthatÌýAVMDÌýis a form ofÌýBest disease. The number of patients suffering fromÌýAVMD is not currently known, though, it is a rarer incidence than Best disease. Typical age of onset of the condition is between 30 to 50 years old. AVMD has also been found to be caused by mutations in the PRPH2 gene, as well as the BEST1 gene.Ìý

How does AVMD affect the eye?ÌýÌý

AVMD is clinically indistinguishable from milder forms of Best disease, with the classical vitelliform ‘egg-yolk’ lesion also usually being present. AVMD has even been said to be a less severe form of Bests,Ìýowing to the fact that it begins later than Bests and also seems to have a much slower progression.ÌýThe ‘egg-yolk’ lesions also appear to be much smaller.ÌýTheseÌýsmaller lesionsÌýmay not necessarily pass through the six clinical stages ofÌýBestÌýdiseaseÌýbut theÌýregion mayÌýstillÌýundergo atrophy (death of the region).ÌýÌý

Schematic of the fundus image of a retina suffering from Best disease. In the centre of the fundus there is the characteristic 'egg-yolk' lesion associated with Best disease.
Ìý

AVMD has a less dramaticÌýeffect on vision,Ìýcompared toÌýBestÌýdisease.ÌýIn general, older patients are diagnosed when changes in their macular region areÌýobserved, these changes may or may not be accompanied by vision loss. Over time, central vision loss can occur, but vision tends to remain stable, however AVMD patients can have complicationsÌýassociatedÌýwith the disease.ÌýVision has been reported to range from 6/12 to 6/60 on theÌýSnellen chart.ÌýÌý

How is AVMD diagnosed?Ìý

Similar toÌýBest disease, OCT imagery can be used toÌýexamineÌýthe macular region, assessing any lesions, RPE structure, lipofuscin deposits and fluid build-up.Ìý

Autofluorescence imaging (FAF and FA)Ìýcan be usedÌýto detect theÌýhyperautofluroscenceÌýseen at earlier stages,ÌýandÌýhypofluorescenceÌýat late stage disease. EOG recordings, however, are usually normal or only slightly reducedÌýin AVMD patients. ERG recordings will also be normal in those suffering with AVMD.ÌýÌý

Suspected cases of AVMD can be confirmed using genetic sequencing.Ìý

Are there any complicationsÌýassociated withÌýAVMD?Ìý

The main complication for AVMD is choroidal neovascularization (CNV).ÌýÌýThis is where new and weak blood vessels,Ìýwhich originate from the choroid,Ìýmake their wayÌýthroughÌýthe RPEÌýlayer of cells. The new blood vessels canÌýeasily rupture and break leading to fluid leakage. TheÌýbuild upÌýof fluid canÌýleadÌýtoÌýpigment epithelial detachment (PED). PED is another complication ofÌýAVMDÌýand it occurs when excess fluid build-up causes the RPE to detach from the underlying choroid.ÌýÌý

What are the treatment options for AVMD?ÌýÌý

ThereÌýareÌýcurrently no medical or surgical treatmentÌýoptions available for AVMD, or any of theÌýbestrophinopathies, howeverÌýresearchÌýis ongoing and promising.ÌýThe complications associated with AVMD can be treated, e.g.Ìýanti-VEGF injectionsÌýused toÌýstop the growth of newer vessels, with the aim to preserve vision.Ìý

ResearchÌýinto treatments for AVMD is ongoing. Patients are encouraged to visit the manyÌýcharities and support groups forÌýbestrophinopathies.Ìý